← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Luna Innovations, Inc.
Roanoke, VA
$24,487,996
Total funding
50
Grants
Funding over time
peak $3.5M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$24,487,996 · 50
By mechanism
R44$6,627,344 · 6
N44$5,721,673 · 4
R43$4,169,111 · 24
N01$2,849,745 · 6
R01$1,492,637 · 1
U44$1,483,149 · 1
Investigators at Luna Innovations, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES$1,999,997
N44 · FY2019 · AI
INNOVATIVE PEDIATRIC ORAL FORMULATIONS FOR SECOND LINE TUBERCULOSIS DRUGS$1,499,998
N44 · FY2021 · AI
A Point-of Care Cytomegalovirus Serodiagnostic$1,499,994
N44 · FY2019 · AI
Innovative Oral Formulations for Anti-Tb Drugs$1,499,796
N01 · FY2018 · AI
Development of RSK Inhibitors as Novel Therapeutics for Yersinia pestis$997,346
R44 · FY2010 · AI
Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis$772,232
U44 · FY2013 · CA
Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis$710,917
U44 · FY2014 · CA
Model Acute Compartment Syndrome Study$602,624
R44 · FY2008 · AR
Development of RSK Inhibitors as Novel Therapeutics for Yersinia pestis$597,452
R44 · FY2008 · AI
Low-Cost Sprayable Barrier for the Prevention of Surgical Adhesions$573,837
R44 · FY2016 · GM
SBIR Topic 37 - Phase II$521,684
N44 · FY2010 · HL
Development of RSK Inhibitors as Novel Therapeutics for Yersinia pestis$497,899
R44 · FY2009 · AI
Sutureless Resorbable Anti-Adhesion Films$459,978
R44 · FY2010 · GM
Validation of a RSK-inhibitor as a Novel Therapeutic for$435,093
R43 · FY2005 · AI
Low-Cost Sprayable Barrier for the Prevention of Surgical Adhesions$424,910
R44 · FY2015 · GM
Sutureless Resorbable Anti-Adhesion Films$406,947
R44 · FY2009 · GM
Miniature Non-Invasive IOP Measurement Device$374,984
R44 · FY2006 · EY
Miniature Non-Invasive IOP Measurement Device$374,865
R44 · FY2005 · EY
Delipidated Adipose Grafts for Craniofacial Reconstruction$373,915
R44 · FY2010 · DE
Delipidated Adipose Grafts for Craniofacial Reconstruction$371,944
R44 · FY2011 · DE